TG Therapeutics, Inc. (NASDAQ:TGTX) Q2 2024 Earnings Call Transcript August 6, 2024
TG Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.04315, expectations were $-0.04.
Operator: Greetings. Welcome to TG Therapeutics’ Conference Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note this conference is being recorded. I’ll now turn...
